Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel-Reference-Cited by-同舟云学术

Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel

Published:2014-11-28 Issue:3 Volume:62 Page:483-489
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Haeusler Gabrielle M.¹²³,Phillips Robert S.⁴⁵,Lehrnbecher Thomas⁶,Thursky Karin A.¹⁷,Sung Lillian⁸,Ammann Roland A.⁹

Affiliation:

1. Department of Infectious Diseases and Infection Control; Peter MacCallum Cancer Centre; Melbourne Australia

2. Department of Infectious Diseases; Monash Children's Hospital; Monash Health; Melbourne Australia

3. Paediatric Integrated Cancer Service; Victoria; Australia

4. Centre for Reviews and Dissemination; University of York; York United Kingdom

5. Paediatric Oncology; Leeds Children's Hospital; Leeds United Kingdom

6. Pediatric Hematology and Oncology; Hospital for Children and Adolescents; University of Frankfurt; Frankfurt Germany

7. Victorian Infectious Diseases Service and Centre for Clinical Research Excellence in Infectious Diseases; Royal Melbourne Hospital; Melbourne Australia

8. Division of Haematology/Oncology; The Hospital for Sick Children; Toronto Canada

9. Department of Pediatrics; University of Bern; Bern Switzerland

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference49 articles.

1. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children;Sinha;PLoS Med,2008

2. The reporting of outcomes in studies of fever and neutropenia in children with cancer: Time for consensus;Haeusler;Pediatr Blood Cancer,2013

3. Can a core outcome set improve the quality of systematic reviews?-A survey of the Co-ordinating Editors of Cochrane Review Groups;Kirkham;Trials,2013

4. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people;Phillips;Eur J Cancer,2010

5. Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia;Phillips;PLoS ONE,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Vitamin A and D Deficiencies with Infectious Outcomes in Children Undergoing Intensive Induction Therapy for Acute Lymphoblastic Leukemia;The Journal of Pediatrics;2024-10

2. Infections in children following chimeric antigen receptor T‐cell therapy for B‐cell acute lymphoblastic leukemia;Transplant Infectious Disease;2023-12

3. Diagnostics and therapy of paediatric patients with febrile neutropenia;EJC Paediatric Oncology;2023-12

4. Prophylactic use of Levofloxacin during induction of acute lymphoblastic leukaemia in children—experience from Pakistan;Journal of the Pakistan Medical Association;2023-09-13

5. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients;Journal of Pediatric Hematology/Oncology;2023-06-26